Neil Turner

Neil Turner is an editor for PPR Communications, which provides pricing and reimbursement information to the global pharma industry. He is also the author of From Commerce to Compassion: A Band-Aid for HIV in Africa.


Pricing Climate Heats Up in US and Europe

In 2003, Big Pharma produced only a dozen new drugs. At the same time, it came under new pressure to create value from those thin pipelines. In that "hot squeeze" of a climate, pharma companies needed price premiums for every product in every market. They were more successful in some countries than in others. Other pricing trends also took their toll.

European Pricing Squeeze

A jittery stock market, repeated profit warnings, concern about accounting practices, another industry mega-merger, and a new raft of legislative proposals. Small wonder that US analysts find it difficult to separate the words "troubled" and "pharmaceutical industry."